PANTOPRAZOLE SODIUM (PANTOPRAZOLE)
PANTOPRAZOLE SODIUM (PANTOPRAZOLE) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: PANTOPRAZOLE SODIUM; Generic name: PANTOPRAZOLE; Manufacturer: XLCare Pharmaceuticals Inc..
| Brand name | PANTOPRAZOLE SODIUM |
|---|---|
| Generic name | PANTOPRAZOLE |
| Manufacturer | XLCare Pharmaceuticals Inc. |
| Used for | 1 INDICATIONS AND USAGE Pantoprazole Sodium Delayed-Release Tablets are indicated for: Pantoprazole sodium delayed-release tablet is a proton pump inhibitor (PPI) indicated for the following: • Short-Term Treatment of Erosive Esophagitis Associated with Gastroesophageal Reflux Disease (GERD) (1.1) • Maintenance of Healing of Erosive Esophagitis ( 1.2) • Pathological Hypersecretory Conditions Including Zollinger-Ellison (ZE) Syndrome (1.3 ) 1.1 Short-Term Treatment of Erosive Esophagitis Associated With Gastroesophageal Reflux Disease (GERD) Pantoprazole Sodium Delayed-Release Tablet is indicated in adults and pediatric patients five years of age and older for the short-term treatment (up to |
| Dosage | 2 DOSAGE AND ADMINISTRATION Indication Dose Frequency Short-Term Treatment of Erosive Esophagitis Associated With GERD ( 2.1 ) Adults 40 mg � Once Daily for up to 8 wks Children (5 years and older) ≥ 15 kg to < 40 kg 20 mg Once Daily for up to 8 wks ≥ 40 kg 40 mg Maintenance of Healing of Erosive Esophagitis ( 2.1 ) Adults 40 mg Once Daily* Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome ( 2.1 ) Adults 40 mg Twice Daily *Controlled studies did not extend beyond 12 mon |
| Active ingredient(s) | PANTOPRAZOLE SODIUM |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17468dbf-84b6-4c53-9ad5-341350d2cfab |